| Authors: |
Bain KA; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Nichols B; Human Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK., Moffat F; Alan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, UK., Kerbiriou C; Human Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK., Ijaz UZ; Department of Infrastructure and Environment, University of Glasgow, Glasgow, UK., Gerasimidis K; Human Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK., McInnes IB; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Åstrand A; Late Phase Development, Respiratory, Immunology & Infection, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Holmes S; Alan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, UK., Milling SWF; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. |
